Cassandra Michelle Kelleher, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Physicians, Women | 5 | 2022 | 508 | 2.440 |
Why?
|
Employment | 4 | 2021 | 1118 | 1.540 |
Why?
|
Specialties, Surgical | 2 | 2021 | 389 | 1.010 |
Why?
|
Esophageal Cyst | 2 | 2016 | 13 | 0.960 |
Why?
|
Workload | 2 | 2021 | 844 | 0.930 |
Why?
|
Parental Leave | 1 | 2021 | 92 | 0.720 |
Why?
|
Hernia, Inguinal | 2 | 2020 | 220 | 0.690 |
Why?
|
Anesthesia, Spinal | 2 | 2020 | 280 | 0.680 |
Why?
|
Esophagus | 2 | 2016 | 1033 | 0.610 |
Why?
|
Insurance | 1 | 2019 | 113 | 0.610 |
Why?
|
Esophageal Achalasia | 1 | 2018 | 94 | 0.590 |
Why?
|
Pelvic Pain | 1 | 2020 | 298 | 0.580 |
Why?
|
Pyloric Stenosis, Hypertrophic | 1 | 2016 | 11 | 0.570 |
Why?
|
Circumcision, Male | 1 | 2018 | 148 | 0.560 |
Why?
|
Esophagoplasty | 1 | 2016 | 48 | 0.540 |
Why?
|
Breast Diseases | 1 | 2019 | 442 | 0.520 |
Why?
|
Referral and Consultation | 3 | 2023 | 3600 | 0.470 |
Why?
|
Adnexal Diseases | 1 | 2015 | 104 | 0.450 |
Why?
|
Surgical Procedures, Operative | 2 | 2024 | 1922 | 0.430 |
Why?
|
Career Choice | 1 | 2019 | 756 | 0.430 |
Why?
|
Operating Rooms | 1 | 2019 | 789 | 0.420 |
Why?
|
Bariatric Surgery | 2 | 2019 | 992 | 0.410 |
Why?
|
Off-Road Motor Vehicles | 2 | 2017 | 17 | 0.400 |
Why?
|
Palliative Care | 2 | 2024 | 3598 | 0.390 |
Why?
|
Obesity, Morbid | 2 | 2019 | 1277 | 0.390 |
Why?
|
Adrenalectomy | 1 | 2013 | 346 | 0.380 |
Why?
|
Reoperation | 2 | 2018 | 4303 | 0.370 |
Why?
|
Pulmonary Alveoli | 1 | 2014 | 652 | 0.370 |
Why?
|
Neuroendocrine Tumors | 1 | 2017 | 641 | 0.370 |
Why?
|
New York | 4 | 2021 | 874 | 0.350 |
Why?
|
Pancreatic Neoplasms | 2 | 2018 | 5368 | 0.340 |
Why?
|
Extracellular Matrix | 2 | 2010 | 1726 | 0.340 |
Why?
|
Postoperative Complications | 5 | 2019 | 15631 | 0.300 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2013 | 732 | 0.300 |
Why?
|
Laparoscopy | 2 | 2020 | 2035 | 0.270 |
Why?
|
Female | 31 | 2024 | 392644 | 0.260 |
Why?
|
Medicare | 2 | 2023 | 6770 | 0.260 |
Why?
|
Child | 15 | 2024 | 80153 | 0.250 |
Why?
|
Adolescent | 17 | 2024 | 88319 | 0.250 |
Why?
|
Infant | 10 | 2024 | 36192 | 0.250 |
Why?
|
Physicians | 1 | 2023 | 4591 | 0.250 |
Why?
|
Neuroblastoma | 1 | 2013 | 1250 | 0.240 |
Why?
|
Nanotechnology | 1 | 2010 | 714 | 0.240 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2491 | 0.240 |
Why?
|
Wounds, Gunshot | 2 | 2021 | 582 | 0.240 |
Why?
|
Retrospective Studies | 17 | 2024 | 80636 | 0.230 |
Why?
|
Accidents | 1 | 2005 | 165 | 0.230 |
Why?
|
Elastin | 1 | 2005 | 298 | 0.220 |
Why?
|
Young Adult | 12 | 2024 | 59243 | 0.220 |
Why?
|
Lung Diseases | 1 | 2014 | 1909 | 0.220 |
Why?
|
California | 2 | 2018 | 1429 | 0.220 |
Why?
|
Male | 25 | 2024 | 360804 | 0.220 |
Why?
|
Intubation, Gastrointestinal | 1 | 2024 | 166 | 0.220 |
Why?
|
Child, Preschool | 10 | 2024 | 42230 | 0.210 |
Why?
|
SEER Program | 2 | 2018 | 1450 | 0.210 |
Why?
|
Humans | 40 | 2024 | 761504 | 0.210 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7390 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6484 | 0.200 |
Why?
|
Stereotyped Behavior | 1 | 2022 | 135 | 0.190 |
Why?
|
Amino Acid Substitution | 1 | 2005 | 1738 | 0.180 |
Why?
|
Relative Value Scales | 1 | 2021 | 84 | 0.180 |
Why?
|
Tissue Engineering | 1 | 2010 | 1868 | 0.180 |
Why?
|
Professional Practice Location | 1 | 2020 | 56 | 0.170 |
Why?
|
Exons | 1 | 2005 | 2391 | 0.160 |
Why?
|
Tourniquets | 1 | 2020 | 107 | 0.160 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2022 | 326 | 0.160 |
Why?
|
Enteral Nutrition | 1 | 2024 | 794 | 0.150 |
Why?
|
Efficiency | 1 | 2021 | 476 | 0.150 |
Why?
|
Gallbladder Diseases | 1 | 2019 | 141 | 0.150 |
Why?
|
Neurotoxins | 1 | 2018 | 240 | 0.150 |
Why?
|
Dilatation | 1 | 2018 | 306 | 0.140 |
Why?
|
Decision Trees | 1 | 2019 | 504 | 0.140 |
Why?
|
Parents | 2 | 2023 | 3563 | 0.140 |
Why?
|
Ultrasonography, Mammary | 1 | 2019 | 239 | 0.140 |
Why?
|
Fetal Diseases | 1 | 2022 | 913 | 0.140 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 589 | 0.140 |
Why?
|
Botulinum Toxins | 1 | 2018 | 189 | 0.140 |
Why?
|
Cholecystectomy | 1 | 2019 | 406 | 0.140 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 583 | 0.130 |
Why?
|
United States | 7 | 2023 | 72334 | 0.130 |
Why?
|
Aorta | 1 | 2004 | 2042 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12148 | 0.130 |
Why?
|
Gonadoblastoma | 1 | 2015 | 14 | 0.130 |
Why?
|
Co-Repressor Proteins | 1 | 2016 | 190 | 0.120 |
Why?
|
Lung | 1 | 2014 | 10000 | 0.120 |
Why?
|
Age Factors | 4 | 2019 | 18395 | 0.120 |
Why?
|
Fallopian Tube Diseases | 1 | 2015 | 60 | 0.120 |
Why?
|
Hysterectomy | 1 | 2020 | 857 | 0.120 |
Why?
|
Infant, Newborn | 6 | 2024 | 26198 | 0.120 |
Why?
|
Extremities | 1 | 2020 | 867 | 0.120 |
Why?
|
Ovarian Cysts | 1 | 2015 | 108 | 0.120 |
Why?
|
Workflow | 1 | 2019 | 851 | 0.110 |
Why?
|
Cohort Studies | 4 | 2023 | 41487 | 0.110 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14605 | 0.110 |
Why?
|
Choice Behavior | 1 | 2020 | 824 | 0.110 |
Why?
|
Adult | 11 | 2021 | 221177 | 0.110 |
Why?
|
Motivation | 1 | 2022 | 2006 | 0.100 |
Why?
|
Bronchogenic Cyst | 1 | 2012 | 28 | 0.100 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1733 | 0.100 |
Why?
|
Teratoma | 1 | 2015 | 404 | 0.100 |
Why?
|
Accidents, Traffic | 1 | 2017 | 816 | 0.100 |
Why?
|
Organ Culture Techniques | 1 | 2014 | 794 | 0.100 |
Why?
|
Reimbursement, Incentive | 1 | 2016 | 543 | 0.100 |
Why?
|
Mediastinal Diseases | 1 | 2012 | 91 | 0.100 |
Why?
|
Genes, Tumor Suppressor | 1 | 2016 | 1062 | 0.090 |
Why?
|
Abscess | 1 | 2015 | 606 | 0.090 |
Why?
|
Patient Discharge | 1 | 2024 | 3443 | 0.090 |
Why?
|
Esophageal Diseases | 1 | 2012 | 168 | 0.090 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21012 | 0.090 |
Why?
|
Linear Models | 1 | 2021 | 5871 | 0.090 |
Why?
|
Signal Transduction | 1 | 2014 | 23445 | 0.090 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 3204 | 0.090 |
Why?
|
Choristoma | 1 | 2012 | 206 | 0.090 |
Why?
|
Gastroschisis | 1 | 2011 | 99 | 0.090 |
Why?
|
Emergency Medical Services | 1 | 2021 | 1923 | 0.090 |
Why?
|
Hernia, Umbilical | 1 | 2011 | 102 | 0.080 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 491 | 0.080 |
Why?
|
Hospitals | 1 | 2023 | 3882 | 0.080 |
Why?
|
Cysts | 1 | 2015 | 681 | 0.080 |
Why?
|
Abdominal Wall | 1 | 2011 | 166 | 0.080 |
Why?
|
Breast | 1 | 2018 | 1967 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2022 | 3249 | 0.080 |
Why?
|
Quality Improvement | 1 | 2024 | 3801 | 0.080 |
Why?
|
Time Factors | 3 | 2021 | 39967 | 0.080 |
Why?
|
Animals, Newborn | 1 | 2014 | 2678 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2508 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2319 | 0.080 |
Why?
|
Hemorrhage | 1 | 2020 | 3424 | 0.070 |
Why?
|
Necrosis | 1 | 2012 | 1611 | 0.070 |
Why?
|
Surface Properties | 1 | 2010 | 1161 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1893 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3358 | 0.070 |
Why?
|
NF-kappa B | 1 | 2016 | 2490 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6766 | 0.070 |
Why?
|
Endometriosis | 1 | 2015 | 870 | 0.070 |
Why?
|
Risk Assessment | 3 | 2019 | 23995 | 0.070 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2024 | 846 | 0.070 |
Why?
|
Databases, Factual | 2 | 2019 | 7967 | 0.070 |
Why?
|
Patient Readmission | 2 | 2019 | 3270 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1961 | 0.070 |
Why?
|
Tropoelastin | 1 | 2005 | 28 | 0.060 |
Why?
|
Sex Factors | 1 | 2019 | 10552 | 0.060 |
Why?
|
Abdominal Pain | 1 | 2012 | 1071 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2005 | 7879 | 0.060 |
Why?
|
Missouri | 1 | 2005 | 114 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10723 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39106 | 0.060 |
Why?
|
Commerce | 1 | 2010 | 606 | 0.060 |
Why?
|
Pancreas | 1 | 2012 | 1691 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2947 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10090 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2014 | 18965 | 0.060 |
Why?
|
Head Protective Devices | 1 | 2005 | 118 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 14031 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11121 | 0.060 |
Why?
|
Trauma Severity Indices | 1 | 2005 | 478 | 0.050 |
Why?
|
Piperacillin | 1 | 2022 | 37 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6814 | 0.050 |
Why?
|
Basement Membrane | 1 | 2004 | 349 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4915 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2013 | 5247 | 0.050 |
Why?
|
Pregnancy | 2 | 2021 | 29874 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26125 | 0.050 |
Why?
|
Endoscopy | 1 | 2012 | 1851 | 0.050 |
Why?
|
Ultrasonography | 1 | 2015 | 5972 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4244 | 0.050 |
Why?
|
Aged | 4 | 2023 | 169289 | 0.050 |
Why?
|
Aging | 1 | 2000 | 8708 | 0.050 |
Why?
|
Proteoglycans | 1 | 2004 | 803 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 64680 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 1702 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2005 | 1093 | 0.040 |
Why?
|
Hypertension | 1 | 2000 | 8540 | 0.040 |
Why?
|
Cattle | 1 | 2005 | 3849 | 0.040 |
Why?
|
Melanoma | 1 | 2018 | 5709 | 0.040 |
Why?
|
Goals | 1 | 2024 | 711 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2024 | 908 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2005 | 3087 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12463 | 0.040 |
Why?
|
Prognosis | 2 | 2017 | 29625 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5821 | 0.040 |
Why?
|
Preventive Medicine | 1 | 2000 | 246 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2014 | 10445 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4876 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2021 | 1045 | 0.040 |
Why?
|
Home Care Services | 1 | 2024 | 648 | 0.040 |
Why?
|
Pedigree | 1 | 2005 | 4542 | 0.040 |
Why?
|
Antifungal Agents | 1 | 2022 | 752 | 0.040 |
Why?
|
New York City | 1 | 2020 | 731 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4111 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12974 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2014 | 11528 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10773 | 0.030 |
Why?
|
Trauma Centers | 1 | 2021 | 937 | 0.030 |
Why?
|
Collagen | 1 | 2004 | 2638 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22169 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9280 | 0.030 |
Why?
|
Patients | 1 | 2021 | 907 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4243 | 0.030 |
Why?
|
Triage | 1 | 2021 | 986 | 0.030 |
Why?
|
Animals | 4 | 2016 | 168459 | 0.030 |
Why?
|
Firearms | 1 | 2021 | 625 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13446 | 0.030 |
Why?
|
Middle Aged | 4 | 2021 | 220895 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 17635 | 0.030 |
Why?
|
Boston | 1 | 2024 | 9326 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20570 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 74206 | 0.020 |
Why?
|
Patient Participation | 1 | 2020 | 1444 | 0.020 |
Why?
|
Mice | 2 | 2016 | 81525 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1739 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2005 | 10209 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2921 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6343 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9420 | 0.020 |
Why?
|
Insurance, Health | 1 | 2020 | 2498 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36426 | 0.020 |
Why?
|
Medicaid | 1 | 2020 | 2818 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6425 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8830 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7407 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 2011 | 1265 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12725 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2000 | 8002 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9539 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21353 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54425 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58976 | 0.010 |
Why?
|
Neoplasms | 1 | 2024 | 22170 | 0.010 |
Why?
|